Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela K Deem

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Nature Communications|April 17, 2023
Ether phospholipids are required for mitochondrial reactive oxygen species homeostasisZiheng Chen, I-Lin Ho, Melinda Soeung, et al.
Cell Reports. Medicine|July 27, 2025
Therapeutic targeting of syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancersMadelaine S Theardy, Mitsunobu Takeda, Alexey Sorokin, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
Therapeutic targeting of Syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancersMitsunobu Takeda, Madelaine S Theardy, Alexey Sorokin, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 2023
SMARCB1 regulates the hypoxic stress response in sickle cell traitMelinda Soeung, Luigi Perelli, Ziheng Chen, et al.
Nature|August 15, 2014
Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial functionAndrea Viale, Piergiorgio Pettazzoni, Costas A Lyssiotis, et al.
Cancer Discovery|May 27, 2021
Medium-Chain Acyl-CoA Dehydrogenase Protects Mitochondria from Lipid Peroxidation in GlioblastomaFrancesca Puca, Fei Yu, Caterina Bartolacci, et al.
Science (New York, N.Y.)|September 16, 2021
Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesisEdoardo Del Poggetto, I-Lin Ho, Chiara Balestrieri, et al.
Gastroenterology|March 22, 2021
Sequential Administration of XPO1 and ATR Inhibitors Enhances Therapeutic Response in TP53-mutated Colorectal CancerAkira Inoue, Frederick S Robinson, Rosalba Minelli, et al.
Nature|March 29, 2019
Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancerWantong Yao, Johnathon L Rose, Wei Wang, et al.
Nature Communications|July 31, 2021
PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinomaVirginia Giuliani, Meredith A Miller, Chiu-Yi Liu, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Nature Communications|April 17, 2023
Ether phospholipids are required for mitochondrial reactive oxygen species homeostasisZiheng Chen, I-Lin Ho, Melinda Soeung, et al.
Cell Reports. Medicine|July 27, 2025
Therapeutic targeting of syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancersMadelaine S Theardy, Mitsunobu Takeda, Alexey Sorokin, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
Therapeutic targeting of Syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancersMitsunobu Takeda, Madelaine S Theardy, Alexey Sorokin, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 2023
SMARCB1 regulates the hypoxic stress response in sickle cell traitMelinda Soeung, Luigi Perelli, Ziheng Chen, et al.
Nature|August 15, 2014
Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial functionAndrea Viale, Piergiorgio Pettazzoni, Costas A Lyssiotis, et al.
Cancer Discovery|May 27, 2021
Medium-Chain Acyl-CoA Dehydrogenase Protects Mitochondria from Lipid Peroxidation in GlioblastomaFrancesca Puca, Fei Yu, Caterina Bartolacci, et al.
Science (New York, N.Y.)|September 16, 2021
Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesisEdoardo Del Poggetto, I-Lin Ho, Chiara Balestrieri, et al.
Gastroenterology|March 22, 2021
Sequential Administration of XPO1 and ATR Inhibitors Enhances Therapeutic Response in TP53-mutated Colorectal CancerAkira Inoue, Frederick S Robinson, Rosalba Minelli, et al.
Nature|March 29, 2019
Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancerWantong Yao, Johnathon L Rose, Wei Wang, et al.
Nature Communications|July 31, 2021
PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinomaVirginia Giuliani, Meredith A Miller, Chiu-Yi Liu, et al.
Pageof 3